Indication

Nocturnal enuresis

Nocturnal enuresis, commonly referred to as bedwetting, is the involuntary voiding of urine during sleep in individuals who have reached a developmental age where nighttime bladder control is expected, typically defined as five years of age or older. Read more about Nocturnal enuresis

32 drugs 31 manufacturers

Advertisement

Drugs that treat it

Common Nocturnal enuresis therapies.

Showing 19–27 of 32 drugs

Filter & compare in the drug finder →Opens the drug finder with Nocturnal enuresis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Nocturnal enuresis.

Nocturnal enuresis, commonly referred to as bedwetting, is the involuntary voiding of urine during sleep in individuals who have reached a developmental age where nighttime bladder control is expected, typically defined as five years of age or older.

Primarily affecting the pediatric population and the urologic and neurological systems governing micturition, it can present as primary, where dryness has never been sustained, or secondary, where symptoms emerge after a period of continence.

The condition is characterized clinically by repeated nighttime wetting episodes and is driven pathophysiologically by a mismatch between nocturnal bladder capacity and urine production—often secondary to nocturnal polyuria from deficient nighttime antidiuretic hormone secretion, detrusor overactivity, and an inability to arouse from sleep in response to bladder fullness.

Personalize your experience

Follow Nocturnal enuresis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it